Opinion

Video

Factors for Consideration When Employing UASs In Patients With Urinary Stones

Author(s):

Michelle Semins, MD,Seth Bechis, MD

Drs Bechis and Semins discuss their approaches to employing ureteral access sheaths, reviewing assessing the ureter's caliber, dilation techniques, and the potential need for stenting post-sheath use, considering patient history and logistical factors like on-call availability.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Sarah Razavi, MD, answers a question during a Zoom video interview
      Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
      Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
      Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Investigators evaluate patient outcomes with silicone vs polyurethane stents
      John Michael DiBianco, MD, answers a question during a Zoom video interview
      John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
      Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
      Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
      Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
      Endourologist discusses shared decision-making and laser lithotripsy
      Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
      Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
      Perry Xu, MD, answers a question during Zoom video interview
      Perry Xu, MD, discusses PCNL’s role in the age of minimally invasive URS
      Related Content
      Blurred interior of hospital - abstract medical background. | Image Credit: © jakkapan - stock.adobe.com
      May 15th 2025

      Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy

      Professor Andreas Skolarikos Hannah Clarke
      Professor Andreas Skolarikos shares his experience with the LithoVue Elite System.
      Why kidney stones will become more prevalent over time
      February 17th 2022

      Why kidney stones will become more prevalent over time

      Urology Times staff
      “The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
      Intervention to increase fluid intake does not reduce recurrent stones
      May 8th 2025

      Intervention to increase fluid intake does not reduce recurrent stones

      Hannah Clarke
      “We do not feel that our results undermine the importance of fluid intake for stone prevention," says Alana C. Desai, MD.
      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters
      September 9th 2021

      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

      Urology Times staff
      “You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.
      Pablo Suarez, MS-4 | Credit: UCSF
      April 26th 2025

      Drinking water contaminants could increase risk of kidney stones, study finds

      Patrick Campbell
      New research links higher drinking water contaminants to increased kidney stone risk.
      Pivotal trial of Break Wave System for stone disease reaches enrollment goal
      April 24th 2025

      Pivotal trial of Break Wave System for stone disease reaches enrollment goal

      Hannah Clarke
      Data from the SOUND trial are intended to support submission for FDA 510(k) clearance of the Break Wave device.
      © 2025 MJH Life Sciences

      All rights reserved.